Logo image of RLMD

RELMADA THERAPEUTICS INC (RLMD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RLMD - US75955J4022 - Common Stock

4.51 USD
-0.09 (-1.96%)
Last: 12/26/2025, 8:14:12 PM
4.69 USD
+0.18 (+3.99%)
After Hours: 12/26/2025, 8:14:12 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RLMD revenue by date.RLMD revenue by date.
N/AN/AN/AN/AN/AN/A
416.30%
N/A
177.57%
N/A
66.82%
EBITDA
YoY % growth
RLMD ebitda by date.RLMD ebitda by date.
-12.95M-17.09M
-31.97%
-16.17M
5.38%
-7.13M
55.91%
-6.92M
2.95%
-12.73M
-83.96%
-60.84M
-377.93%
-125.7M
-106.61%
-161.25M
-28.28%
N/A
34.29%
N/A
15.94%
N/A
-18.54%
N/A
-20.77%
N/AN/AN/A
-14.71%
N/A
44.44%
N/A
206.15%
N/A
208.70%
EBIT
YoY % growth
RLMD ebit by date.RLMD ebit by date.
-12.95M-17.1M
-32.05%
-16.22M
5.15%
-7.22M
55.49%
-6.92M
4.16%
-12.73M
-83.96%
-60.84M
-377.93%
-125.7M
-106.61%
-161.25M
-28.28%
-103.702M
35.69%
-83.891M
19.10%
N/A
40.18%
N/A
4.27%
N/A
-18.90%
N/A
-81.61%
N/A
-14.75%
N/A
44.64%
N/AN/A
Operating Margin
RLMD operating margin by date.RLMD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
RLMD eps by date.RLMD eps by date.
N/AN/AN/A
92.46%
N/AN/AN/AN/A-7.14
-93.19%
-5.45
23.67%
-3.28
39.82%
-2.65
19.21%
N/A
52.66%
N/A
52.85%
N/A
-20.69%
N/A
-40.00%
N/A
-11.22%
N/A
55.96%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25
EPS
Q2Q % growth
-0.06
90.38%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-12.036M
36.90%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.30
58.33%
-0.12-0.18-153.55%
Q2 2025
Q2Q % growth
-0.30
49.15%
-0.26-0.04-17.65%
Q1 2025
Q2Q % growth
-0.58
19.44%
-0.32-0.26-83.43%
Q4 2024
Q2Q % growth
-0.62
26.19%
-0.710.0912.98%
Q3 2024
Q2Q % growth
-0.72
1.37%
-0.65-0.07-10.12%
Q2 2024
Q2Q % growth
-0.59
29.76%
-0.840.2530.01%
Q1 2024
Q2Q % growth
-0.72
17.24%
-0.870.1516.90%
Q4 2023
Q2Q % growth
-0.84
40.43%
-0.850.010.78%
Q3 2023
Q2Q % growth
-0.73
44.27%
-0.930.2021.61%
Q2 2023
Q2Q % growth
-0.84
36.84%
-0.910.078.17%
Q1 2023
Q2Q % growth
-0.87
37.86%
-0.910.044.08%
Q4 2022
Q2Q % growth
-1.41
21.67%
-1.35-0.06-4.12%
Q3 2022
Q2Q % growth
-1.31
46.31%
-1.480.1711.40%
Q2 2022
Q2Q % growth
-1.33
14.74%
-1.30-0.03-2.42%
Q1 2022
Q2Q % growth
-1.40
-4.48%
-1.29-0.11-8.45%
Q4 2021
Q2Q % growth
-1.80
-37.40%
-1.870.073.57%
Q3 2021
Q2Q % growth
-2.44
-132.38%
-1.63-0.81-49.82%
Q2 2021
Q2Q % growth
-1.56
-113.70%
-1.50-0.06-3.81%
Q1 2021
Q2Q % growth
-1.34
-212.79%
-1.420.085.78%
Q4 2020
Q2Q % growth
-1.31
-256.75%
-1.18-0.13-10.84%
Q3 2020
Q2Q % growth
-1.05 -0.88-0.17-19.01%
Q2 2020
Q2Q % growth
-0.73 -0.60-0.13-22.34%
RLMD Yearly EPS VS EstimatesRLMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
RLMD Yearly Revenue VS EstimatesRLMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 36.27% 36.27%
RevenueN/A N/A N/A N/A